Objective: To investigate the extent to which preferred drug lists and tiered formularies reflect evidence of value, as measured in published cost-utility analyses (CUAs). Methods: Using 1998-2001 ...

As more high-cost drugs reach the market, the meaning of value gains more attention, especially in the specialty pharmacy market. One way to assess value is to use a cost-effectiveness analysis to ...

CVS Caremark will expand the use of lower-cost biosimilars across multiple therapeutic categories effective July 1.

Delving deep into drug prices often requires a special vocabulary. Here are some definitions of frequently used terms to help you out on your journey. This is similar to "step therapy," a provision in ...

As 2026 begins, CareFirst BCBS is implementing a suite of changes that go beyond standard annual updates, including a major ...

That’s because drug prices and payments are negotiated as part of a package of drugs that are covered by the insurer called a ...

CVS announced Tuesday it will expand its use of lower-cost biosimilars and tr | The move to prioritize biosimilars comes as ...

Health-system pharmacies can advance their goal of eliminating harm due to medication errors through the use of updated data from FormularyPlus™ The Baxa DoseEdge System now features a more easily ...

Recent press reports and other evidence suggest that Medicare Part D plans may be encouraging the use of brand-name drugs instead of generics. However, the scope of such practices is unclear. We ...

FORT RUCKER, Ala. (June 19, 2014) -- The Lyster Army Health Clinic Pharmacy has expanded its medication list over the past three years to better serve its retiree population and make filling ...

CVS Health (NYSE: CVS) today announced updates to its most common commercial template formularies that will expand the use of lower-cost biosimilars across multiple therapeutic categories, including ...